RESUMO
BACKGROUND: Some studies suggest that obesity and metabolic syndrome are frequent in cancer survivors. In our country, there is a lack of documentation with regards to this problem in women. Therefore, our aim is to establish the prevalence of obesity and metabolic syndrome components in surviving Mexican women. METHODS: We elected women who received treatment for cancer with a surviving = 24 months. The data evaluated were demography, clinical anthropometry, blood pressure measurement, kind of cancer, surviving time, and comorbidities, as well as glucose, cholesterol, and triglyceride levels. RESULTS: We studied 107 women. Their average age was 60 ± 10 years, with a surviving time of 77 ± 43 months, and a body mass index of 31 ± 6 kg/m2. Their mean glucose level was 120 ± 58 mg/dL, cholesterol 228 ± 43 mg/dL, and triglycerides 207 ± 120 mg/dL. There were 55 (51 %) with glucose > 99 mg/dL, 85 (79 %) with cholesterol > 199 mg/dL, and 67 (63 %) with triglycerides > 149 mg/dL. Obesity (body mass index = 30 kg/m2) occurred in 49 (46 %) and metabolic syndrome in 27 (26 %). CONCLUSIONS: Due to a high prevalence of obesity, metabolic syndrome components were frequent.
Introducción: algunos estudios sugieren que la obesidad y el síndrome metabólico son frecuentes en supervivientes al cáncer. En nuestro medio no hay datos al respecto en relación con las mujeres. El objetivo de este estudio fue determinar la frecuencia de obesidad y componentes del síndrome metabólico en mujeres supervivientes al cáncer. Métodos: elegimos a mujeres que recibieron tratamiento para cáncer con supervivencia = 24 meses. Se evaluaron datos demográficos y de antropometría clínica, tensión arterial, tipo de neoplasia, tiempo de supervivencia, comorbilidades y niveles séricos de glucosa, colesterol total y triglicéridos. Resultados: estudiamos a 107 individuos, edad promedio de 60 ± 10 años, supervivencia de 77 ± 43 meses e índice de masa corporal de 31 ± 6 kg/m2. La glucosa promedio fue de 120 ± 58 mg/dL, el colesterol de 228 ± 43 mg/dL y los triglicéridos de 207 ± 120 mg/dL. Hubo 55 (51 %) con glucosa > 99 mg/dL, 85 (79 %) con colesterol > 199 mg/dL y 67 (63 %) con triglicéridos > 149 mg/dL. Tuvieron obesidad (índice de masa corporal = 30 kg/m2) 49 (46 %) y síndrome metabólico 27 (26 %). Conclusión: debido a la prevalencia de obesidad, los componentes del síndrome metabólico fueron frecuentes.
Assuntos
Síndrome Metabólica/epidemiologia , Neoplasias , Obesidade/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , SobreviventesRESUMO
INTRODUCTION: According to developed countries' studies, in breast cancer survivors there is a high prevalence of metabolic syndrome; however, in Mexico data is lacking about this issue. GOAL: To explore if metabolic syndrome occurs in Mexican women survivors of breast cancer. MATERIAL AND METHODS: At a second-level general hospital, women with breast cancer with a surviving > 2 years were studied. The analysis involved their demographic and anthropometric features, blood pressure measurement, time of surviving, besides fasting blood levels of lipids and glucose. RESULTS: The sample consisted of 100 women; 42% were obese (body mass index > or = 30 kg/m2). The sample's mean age was 60 years with a mean surviving time of 6.5 years. Their mean glucose level was 122 mg/dL and triglycerides 202 mg/dL. There were 33% with blood pressure > or = 130/85mm Hg or diagnosis of hypertension. Fifty-seven percent had glucose > 99 mg/dL or diagnosis of diabetes mellitus, and 58% had triglycerides > 149 mg/dL. Metabolic syndrome occurred in 57% of obese women. CONCLUSION: Our results suggest that metabolic syndrome occurs in more than 50% of obese Mexican women survivors of breast cancer.